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Objective. To evaluate the long-term outcome of greater saphenous vein (GSV) infrapopliteal revascularisation in a single
centre over a 10 year period.
Material and methods. Fourty-one variables relating to a consecutive series of 90 crural artery GSV(76% in situ) bypasses
in 81 patients (1990–2000) were analysed. The mean age of the 47 men and 34 women was 70 years. Limb-threatening
ischaemia was present in 96% of cases, claudication in four patients. In 18 patients, surgery was ‘redo’.
Results. The perioperative mortality was 3% (n ¼ 3). Patient survival was 54% at 4 years. Independent risk factors
affecting survival were chronic renal insufficiency (p ¼ 0.04), hypertension (p ¼ 0.02), and ischaemic heart disease
(p ¼ 0.01). Four bypasses thrombosed within 30 days. Three of them could be successfully reopened. Mean follow-up was 39
months. The primary patency rate at 4 years was 80%. Chronic renal insufficiency revealed to be the single independent risk
factor for graft thrombosis (p ¼ 0.03, RR ¼ 12.4). The 4-year limb salvage rate was 88%. No independent risk factor
affecting the limb salvage could be identified.
Conclusion. Crural artery revascularisation is a valuable option for the management of limb threatening infrapopliteal
arterial occlusive disease.
Key Words: Femorocrural bypass; Limb salvage; Graft patency; Lower limb revascularisation.
Introduction
Most vascular surgeons agree that femorodistal
bypass with autogenous conduit remains the treat-
ment of choice for patients with limb-threatening
ischaemia.1 – 8 Over the last decade, we pursued an
aggressive policy of distal arterial reconstruction in
elderly patients with threatening limb loss. The
present study analyses the results obtained with distal
infrapopliteal bypass surgery for limb salvage using
the greater saphenous vein during the period 1990–
2000.
Material and Methods
A database of vascular surgery has been prospectively
maintained in our centre since 1988. A retrospective
analysis of this computerized Vascular Surgery Reg-
istry revealed 90 infrapopliteal bypass grafts with the
greater saphenous vein performed in the period of
January 1990 to December 2000. This represents 7% of
all infrainguinal revascularisations performed in the
same time period. Endovascular procedures on the
crural arteries are not performed in our centre. It
concerns 81 patients of whom eight benefited bilateral
tibial artery revascularisation and one had two distal
bypass procedures on the same leg. There are 47 male
and 34 female patients, with a mean age of 70 years
(range: 37–93 years). For each case, a total of 41
variables were recorded. This includes 18 patient-
related variables (demographic data, vascular risk
factors, indications, past medical history, arterial run-
off — summarised in Table 1), 16 procedure-related
variables (graft material used, sites of anastomosis,
type of surgical intervention, operative outcome), and
seven follow-up variables, including patency rate,
limb salvage, and survival. For follow-up, we gathered
information from the out-patient clinic (at our centre
or at another vascular centre) ðn ¼ 75Þ and from phone
call to the general practitioner or to the patient if the
last visit was 6 months or before ðn ¼ 10Þ: Information
gathered by phone call was limited to freedom of limb
ischemia, freedom of amputation and survival.
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Patients were declared ‘lost to follow-up’ when no
patient contact had occurred within 18 months.
All patients were preoperatively investigated by
intraarterial angiography ðn ¼ 75Þ or by magnetic
resonance angiography ðn ¼ 15Þ: Arteriography
revealed segmental to total occlusion of all three crural
vessels in 17 limbs (19%). In three patients no distal
outflow artery was visualised on angiography, but a
patent distal crural vessel or pedal artery was
evidenced by colour echoduplex scan, and this vessel
was surgically exposed as target vessel. A single crural
vessel was patent over its whole length in 47 limbs
(52%), two vessels were patent in 18 legs (20%) and in
eight legs (9%) all three crural vessels were patent. The
indication for distal infrapopliteal bypass grafting was
chronic critical limb ischemia in 96% of the cases (a
case is defined as a revascularisation procedure,
n ¼ 90). It concerned ischemic rest pain (30%),
ischemic non-healing ulceration (12%), toe gangrene
(38%) and heel gangrene (15%). For four patients, the
indication to tibial artery revascularisation was inca-
pacitating claudication. For 20% of the operations, it
concerned a secondary procedure, performed after a
previous failed infrainguinal revascularisation. The
procedures were preferentially done under locoregio-
nal anaesthesia (peridural in 54%, rachianaesthesia in
23%). In 23% of the operations, general anaesthesia
was used. The most common technique was in situ
greater saphenous vein (GSV) bypass grafting (68
procedures, 76%). A reversed GSV was used for 22
distal bypasses (24%), of which eight were done with
the contralateral GSV.
During the same study period, 17 patients benefited
crural artery revascularisation with other bypass
material than the greater saphenous vein (seven
spliced veins, eight cryopreserved arterial allografts,
one lesser saphenous vein and one prosthesis). These
cases are not included in this study. The number of
primary major amputations for unreconstructable
arterial disease could be limited to 28 cases over the
same time period (it mainly concerned dialysed
patients ðn ¼ 21Þ). This number was twice as high in
the previous decade (58 primary amputations from
1980 to 1990).
The anastomotic sites are listed in Table 2. To obtain
a tension-free proximal anastomosis of in situ grafts,
we did not hesitate to select the proximal disease-free
superficial femoral artery or the deep femoral artery as
inflow source. In 16 patients, we preferred a short
bypass graft, originating from the distal unobstructed
superficial femoral artery ðn ¼ 7Þ; the proximal popli-
teal ðn ¼ 3Þ; or distal popliteal artery ðn ¼ 6Þ: A
reversed GSV was always used in these cases. The
distal anastomotic site was chosen in function of the
angiographic images, so that the revascularised target
artery was directly on-line with the ischemic area. Ten
patients had an inframalleolar arterial revascularisa-
tion. In 12 patients, two different distal anastomoses
were performed with a bifurcated saphenous vein
graft ðn ¼ 7Þ or with a vein segment sutured on the
main graft ðn ¼ 5Þ: Since 1998 we routinely used the
pneumatic tigh tourniquet to exsanguinate the limb, in
order to obtain a bloodless operative field and an
atraumatic hemostasis for the distal anastomosis. This
technique has been described in detail elsewhere.9
The revascularisation procedure was completed by
a concomitant limited toe amputation in 17 cases, by a
forefoot amputation in one case and by a free tissue
transfer in four cases. The mean operating time was
230 min (range: 150–350 min).
Table 1. Demographics and comorbidities of the 81 patients who benefited crural artery revascularisation.
Mean age 70 (range: 37–93 years)
Men/women 47/34
Smoking 45 (56%)
Diabetes 35 (43%) (17% insulin dependent) (26% non-insulin dependent)
Coronary artery disease 40 (49%)
Hypertension 39 (48%)
Hypercholesterolemia 35 (43%) serum cholesterol values of 6.47 mmol/l or more or dyslipidemia
requiring a lipid lowering drug regimen
Chronic renal insufficiency 16 (20%) (8 on dialysis) persistent serum creatinine level greater than 0.15 mmol/l
Previous ipsilateral limb revascularisation 16 (20%)
Table 2. Anastomotic sites for crural artery revascularisation.
Proximal anastomosis ðn5 90Þ
Common femoral artery 26 (29%)
Proximal SFA 31 (34%)
DFA 17 (19%)
Distal SFA (above-knee) 7 (8%)
Proximal popliteal artery 3 (3%)
Distal popliteal artery 6 (7%)
Distal anastomosis ðn5 102Þ
Anterior tibial artery 26 (26%)
Posterior tibial artery 36 (36%)
Peroneal artery 30 (30%)
Dorsalis pedis artery 4 (4%)
Retromalleolar post-tibial artery 4 (4%)
Plantar artery 2 (2%)
NB: 12 patients had two distal anastomoses; SFA, supericial femoral
artery; DFA, deep femoral artery.
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At the end of the operation, a continuous wave
Doppler investigation is made of the bypass graft.
Patency and limb salvage rates were defined and
presented in accordance with the recommendations of
the Ad Hoc Committee on Reporting Standards of the
Joint Council of the Vascular Societies.10 Primary
patency was defined as uninterrupted patency of the
original graft without the need for any graft directed
intervention. Assisted primary patency considers
patency obtained with some graft revisions before
occlusion. Secondary patency also includes reopened
grafts. Limb salvage was defined as retention of a
functional lower extremity without need for amputa-
tion proximal to the tarsal–metatarsal junction (free-
dom from transtibial or above-knee amputation).
During late follow-up graft patency was monitored
by clinical examination, supplemented by segmental
blood pressure measurements at the lower limb, at
regular intervals (at 6 weeks, and every 4 months
thereafter for the first year, and then biannually). Since
1999, all distal bypass grafts are routinely surveyed
with colour duplex echography in the non-invasive
vascular laboratory. When the segmental blood press-
ure decreased by 15 mmHg or more, compared to the
postoperative value, or when focal flow disturbances
(peak systolic velocity of 300 cm/s, or a decreased
overall graft velocity of less than 45 cm/s), an
arteriography was performed to investigate the
causative stenosis.
Statistics
Results were expressed as mean ^ S.E. (standard
error) for quantitative variables and as counts and
proportions (%) for categorical findings. Classical
Kaplan–Meier survival curves and life-tables were
used to display postoperative revascularisation results
and primary outcome variables (patency, limb salvage
and survival). Kaplan–Meier survival curves were
associated with 95% confidence intervals. Subgroups
were compared by the Log rank test.
To assess the predictive value of the variables (age,
gender, smoking, diabetes, coronary artery disease,
hypertension, hypercholesterolemia, renal insuffi-
ciency, type of graft material, site of distal anastomo-
sis) that could affect mortality, graft thrombosis and
amputation, a multivariate Cox proportional hazards
regression analysis was done. Results were considered
to be significant at the 5% critical level ðp , 0:05Þ after
adjusting for multiple testings. All calculations were
performed using SAS (version 8.02 for Windows) and
S-PLUS (version 6.1) statistical software package.
Results
The operative mortality rate was 3%. Of the three in-
hospital deaths, two were related to cardiovascular
disease (two myocardial infarctions). Another death
was secondary to sepsis-induced multiorgan failure.
No significant risk factor could be linked to the
perioperative mortality.
Nine patients required an early reintervention in
the postoperative period: thrombectomy in four
patients (successful in three), ligation of an arteriove-
nous fistula of an in situ bypass graft in three and
revision for bleeding from an eroded graft in two (one
could be preserved by interposition of a new vein
segment). Overall, two grafts were occluded when the
patient left the hospital. One patient required early
above-knee amputation for progressive infection of
the heel necrosis, despite an open distal bypass graft.
In all but five patients, the tissue loss or minor
amputation healed within 2 months, as a result of
the crural artery revascularisation.
The mean length of follow-up was 39 (range: 0–96)
months. Three patients were lost to follow-up (at 6
weeks, 6 months, and 1 year, respectively). During
follow-up, 12 reinterventions were done on the bypass
graft (one thrombectomy, two fibrinolyses, five liga-
tions of missed arteriovenous fistula of in situ GSV
grafts, three prolongations of the bypass graft, and one
vein patch). Nine of the late interventions were done
on a failing graft to prevent thrombosis, while three
revisions were done to reopen a thrombosed graft.
Overall, four distal bypass grafts thrombosed during
follow-up after a mean delay of 13 (range: 1–54)
months. This results in a primary patency rate at 4
years of 80% (Fig. 1). The assisted-primary patency
was 82% at 4 years and the secondary patency rate
attains 86% at 4 years. The sole independent prog-
nostic factor predictive for graft occlusion is chronic
renal insufficiency ðp ¼ 0:003Þ: For patients with renal
insufficiency (n ¼ 16; of whom 10 were on dialysis),
the relative risk (RR) for graft thrombosis (early or late)
is 12.4 (confidence interval 2.3–66.3). The primary
patency rate was compared for the different levels of
distal anastomosis (proximal versus distal crural
artery, crural artery versus pedal artery), but no
significant difference was observed ðp ¼ 0:14Þ:
Overall, eight patients required major amputation
(five below-knee, three above-knee) during follow-up,
after a mean delay of 10.4 months (extremes 2 and 61
months). Five of the late amputations were the
consequence of graft thrombosis. Of the four early
postoperative graft thromboses, two ended up with
amputation at 2 and 8 months, respectively. Of the four
late graft thromboses, three ended up with amputation.
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Three patients were amputated with a patent distal
bypass graft for persistent rest pain in two and
extensive heel gangrene in one patient. The cumulat-
ive limb salvage rate was 88% at 4 years (Fig. 2). No
independent risk factor predictive for amputation
could be identified. Eighty-two percent of the patients
operated on for limb salvage regained an autonomic
walking capability. Of the nine patients who were
Fig. 1. Primary graft patency of 90 infrapopliteal bypass grafts, according to Kaplan–Meier method. The dotted line on both
sides of the curve represents the 95% lower and upper confidence intervals. The curve becomes a dash line when the standard
error (SE) exceeds 10% (indicating lack of reliability of the estimate). At 60 months, the mean patency rate is estimated at
64.0 ^ 15.2%. The numbers at the bottom of the graphic correspond to the number of grafts at risk at the beginning of each
time interval (observation period).
Fig. 2. Actuarial limb salvage estimate. The dotted line at both sides of the curve, delimits the 95% confidence interval.
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amputated (five below-knee and four above-knee),
only three (33%) of them were able to walk with their
prostheses (two below-knee and one above-knee
amputee).
There were 24 late deaths. The main cause of death
was cardiac ðn ¼ 15Þ: Other causes were stroke ðn ¼ 3Þ;
cancer ðn ¼ 5Þ; and unknown ðn ¼ 1Þ: The 4-year
survival rate was 54% (Fig. 3). Independent risk
factors predictive for late death are renal insufficiency
ðp ¼ 0:04Þ; hypertension ðp ¼ 0:02Þ; and ischemic heart
disease ðp ¼ 0:01Þ: Patients with renal dysfunction
were at highest risk of death (RR ¼ 6.03, confidence
interval 1.01–35.9), followed by patients with coronary
artery disease (RR ¼ 4.13, confidence interval 1.33–
12.8). The subgroup of patients on hemodialysis ðn ¼
10Þ had the worst outcome. Their mean survival was
20 months. Primary patency was 40% at 2 years, with a
limb salvage rate of 70% at the same time.
Discussion
In the present series, although only half of the patients
were alive at 4 years, 88% of those who were operated
on had avoided major limb amputation of the operated
leg. Three variables affect the late mortality (chronic
renal insufficiency, coronary artery disease, and
hypertension), and one variable was predictive for
graft thrombosis (chronic renal insufficiency).
Although the vast majority of surgeons agree that
autogenous material should be used whenever possible,
controversy continues around the details of technique,
e.g. in situ vs. reversed, use of fistulae, bifurcated
grafts, siting of the proximal and distal anastomosis,
use of arm vein4,7,11 – 15 (Fig. 4). For example, several
authors have confirmed the adequacy of the popliteal
artery as an inflow source, and it reduces the length of
conduit required. In general, the results obtained with
arm veins, composite or spliced veins and lesser
saphenous vein are inferior to GSV.12,16-18 The success
rate obtained with arterial allografts is only half that of
GSV19 and the results of vein cuffs and collars are often
disappointing.20 The role of angioplasty remains
controversial.21,22
In keeping with many other series, chronic renal
insufficiency was a significant negative predictive
factor for graft patency.23 – 26 However, in selected
patients, bypass may still be a better option than
primary amputation.8,23 The results of pedal bypass
surgery (revascularisation of inframalleolar plantar
or of the dorsalis pedis artery) are comparable to
those obtained for crural artery revascularisation
(Tables 3 and 4).5,7,27 – 30 However, early or late graft
failure remains a matter of concern.31 In this series, we
also observed a 5% postoperative graft failure rate. The
aetiology is multifactorial, including surgical technical
Fig. 3. Actuarial patient survival curve. At 60 months the estimated survival rate is 46.3 ^ 10.4%.
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errors and poor patient selection. Graft surveillance32,33
appears logical but as it lacks a level I evidence base,
remains controversial. It is noteworthy that four
patients in this series required major amputation
(half of all the amputations) despite a patent bypass.
Deep ischaemic ulcers exposing bones, joints or
tendons, or locating in weight-bearing areas, require
coverage with free flaps.34,35 (Fig. 5).
In conclusion, this retrospective single centre study
suggests that this time consuming limb-saving pro-
cedure is worth its effort, since it offers an 88% limb
salvage rate at 5 years. The natural history of critical
limb ischemia is worse, with half of the limbs evolving
to amputation if not revascularised. A weak point of
this retrospective study is its heterogeneity (a hetero-
geneous patient cohort and different anastomotic
sites). It is the authors’ conviction that crural artery
revascularisation with an autologous vein bypass graft
is the best option to be offered to the patient with limb
Fig. 4. Bilateral popliteo–pedal venous bypass grafts (to the
plantar artery at the right and the dorsalis pedis artery at the
left).
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threat and infrapopliteal arterial occlusive disease. The
benefit of crural artery revascularisation is less evident
for dialysed patients, who can be considered as poor
candidates for this procedure.
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